Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor
Bioconjugate Chemistry · 18.10.2023 · 34 (10) · 1780-1788
DOI: 10.1021/acs.bioconjchem.3c00332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 22.09.2023. Verfasst von Miyako Naganuma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Organic Chemistry, National Institute of Health Sciences, Kanagawa 210-9501, Japan. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Receptors, Estrogen, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Proteolysis-targeting chimeras (PROTACs) have attracted attention as a chemical method of protein knockdown via the ubiquitin-proteasome system. Some oligonucleotide-based PROTACs have recently been developed for disease-related proteins that do not have optimal small-molecule ligands such as transcription factors. We have previously developed the PROTAC LCL-ER(dec), which uses a decoy oligonucleotide as a target ligand for estrogen receptor α (ERα) as a model transcription factor. However, LCL-ER(dec) has a low intracellular stability because it comprises natural double-stranded DNA sequences. In the present study, we developed PROTACs containing chemically modified decoys to address this issue. Specifically, we introduced phosphorothioate modifications and hairpin structures into LCL-ER(dec). Among the newly designed PROTACs, LCL-ER(dec)-H46, with a T4 loop structure at the end of the decoy, showed long-term ERα degradation activity while acquiring enzyme tolerance. These findings suggest that the introduction of hairpin structures is a useful modification of oligonucleotides in decoy oligonucleotide-based PROTACs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Organic Chemistry, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
- Graduate School of Medical Life Science, Yokohama City University, Kanagawa 236-0027, Japan.
- Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
- Laboratory of Targeted Protein Degradation, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 110-0033, Japan.
ORCID-Profile: Nobumichi Ohoka, Genichiro Tsuji, Mikihiko Naito, Yosuke Demizu
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Naganuma, M., Ohoka, N., Tsuji, G., Inoue, T., Naito, M., & Demizu, Y. (2023). Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor. Bioconjugate Chemistry, 34(10), 1780-1788. https://doi.org/10.1021/acs.bioconjchem.3c00332
Vancouver
Naganuma M, Ohoka N, Tsuji G, Inoue T, Naito M, Demizu Y. Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor. Bioconjugate Chemistry. 2023;34(10):1780-1788. doi:10.1021/acs.bioconjchem.3c00332
BibTeX
@article{Naganuma2023,
author = {Naganuma, Miyako and Ohoka, Nobumichi and Tsuji, Genichiro and Inoue, Takao and Naito, Mikihiko and Demizu, Yosuke},
title = {Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor},
journal = {Bioconjugate Chemistry},
year = {2023},
volume = {34},
number = {10},
pages = {1780--1788},
doi = {10.1021/acs.bioconjchem.3c00332}
}
EUVIMED